Early Aggressive Parenteral Nutrition Induced High Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) Levels Can Prevent Risk of Retinopathy of Prematurity
- PMID: 24427493
- PMCID: PMC3883369
Early Aggressive Parenteral Nutrition Induced High Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) Levels Can Prevent Risk of Retinopathy of Prematurity
Abstract
Objective: To evaluate early aggressive vs. conservative nutrition and its effect on Retinopathy of Prematurity (ROP) in <32 weeks of gestation neonates.
Methods: A prospective, randomized, clinical study was conducted in NICU with a total of 75 preterm infants. In the intervention group, infants received early aggressive nutrition immediately after birth, in the control group infants were started on conventional parenteral nutrition (PN). Blood samples were obtained for Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) levels before commencement of PN on the first postnatal day, and from week 1 to 6 every week. All the infants were examined for ROP.
Findings: Infants in the early aggressive group had a reduction in the risk of ROP of 5% (2 from 40); the number of infants needed treatment averaged 3.7 (2.7 to 5.2). A total of 11 neonates in the conventional group were detected having ROP (P<0.05). Overall, IGF-I levels were higher in the aggressive PN (APN) vs the conventional PN (CPN). ROP development was higher in the CPN compared to the APN. IGF-1levels were lower in ROP developers compared with non-ROP in the APN group. There was no difference in IGF-I levels in ROP developers versus non-ROP in the CPN group. IGF-1 levels were lower in the CPN group compared with the APN group in the third week in ROP developers. There was a correlation between ROP and IGF-1 levels. Through ROC analysis, IGF-1 was demonstrated as being a sensitive marker for ROP.
Conclusion: IGF-1 levels were higher in the APN group versus the CPN group. This may indicate that IGF-1 levels simply being higher is not enough; rather, that being higher above a cutoff value may prevent ROP.
Keywords: IGF-1; IGFBP3; Parenteral nutrition; Prematurity; Retinopathy of prematurity.
Figures


Similar articles
-
Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants.Pediatr Int. 2012 Dec;54(6):869-74. doi: 10.1111/j.1442-200X.2012.03713.x. Epub 2012 Nov 6. Pediatr Int. 2012. PMID: 22882288 Clinical Trial.
-
Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.Arch Ophthalmol. 2006 Dec;124(12):1711-8. doi: 10.1001/archopht.124.12.1711. Arch Ophthalmol. 2006. PMID: 17159030
-
[Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].Klin Oczna. 2009;111(10-12):302-6. Klin Oczna. 2009. PMID: 20169883 Polish.
-
Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.Neonatology. 2016;109(4):369-76. doi: 10.1159/000444901. Epub 2016 Jun 3. Neonatology. 2016. PMID: 27251645 Review.
-
Retinopathy of prematurity.Angiogenesis. 2007;10(2):133-40. doi: 10.1007/s10456-007-9066-0. Epub 2007 Feb 27. Angiogenesis. 2007. PMID: 17332988 Review.
Cited by
-
Retinopathy of prematurity: Past, present and future.World J Clin Pediatr. 2016 Feb 8;5(1):35-46. doi: 10.5409/wjcp.v5.i1.35. eCollection 2016 Feb 8. World J Clin Pediatr. 2016. PMID: 26862500 Free PMC article. Review.
-
Late Growth and Changes in Body Composition Influence Odds of Developing Retinopathy of Prematurity among Preterm Infants.Nutrients. 2019 Dec 27;12(1):78. doi: 10.3390/nu12010078. Nutrients. 2019. PMID: 31892145 Free PMC article.
-
The progress of prophylactic treatment in retinopathy of prematurity.Int J Ophthalmol. 2018 May 18;11(5):858-873. doi: 10.18240/ijo.2018.05.24. eCollection 2018. Int J Ophthalmol. 2018. PMID: 29862189 Free PMC article. Review.
-
A predictive score for retinopathy of prematurity by using clinical risk factors and serum insulin-like growth factor-1 levels.Int J Ophthalmol. 2017 Nov 18;10(11):1722-1727. doi: 10.18240/ijo.2017.11.14. eCollection 2017. Int J Ophthalmol. 2017. PMID: 29181317 Free PMC article.
-
Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 as early predictors of growth, body composition, and neurodevelopment in preterm infants.J Perinatol. 2024 Nov;44(11):1617-1623. doi: 10.1038/s41372-024-01933-3. Epub 2024 Apr 1. J Perinatol. 2024. PMID: 38561392
References
-
- Hagadorn JI, Richardson DK, Schmid CH, et al. Cumulative illness severity and progression from moderate to severe retinopathy of prematurity. J Perinatol. 2007;27(8):502–9. - PubMed
-
- Bang P, Westgren M, Schwander J, et al. Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by radioimmuno-assay in human fetal serum. Pediatr Res. 1994;36(4):528–36. - PubMed
-
- D'Ercole AJ, Willson DF, Underwood LE. Changes in the circulating form of serum somatomedin-C during fetal life. J Clin Endocrinol Metab. 1980;51(3):674–6. - PubMed
-
- Langford K, Nicolaides K, Miell JP. Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod. 1998;13(5):89–93. - PubMed
-
- Hellstrom A, Carlsson B, Niklasson A, et al. IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab. 2002;87(7):3413–6. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous